In today’s briefing:
- Fermi Inc. (FRMI): Peeking at the IPO Prospectus of a Hyperscaler Development Company
- Medcaptain Medical Technology Pre-IPO Tearsheet
- Pattern Group IPO: From Shaky Open to Strong Close as Buyers Step In
Fermi Inc. (FRMI): Peeking at the IPO Prospectus of a Hyperscaler Development Company
- Their mission is to deliver up to 11 gigawatts on-demand power directly to the world’s most compute-intensive businesses with 1 GW of power projected to be online by 2026.
- A pair of hyperscalers have gone public and have been well-received by the market: CoreWeave (CRWV US) and Whitefiber (WYFI US).
- The company has no revenues and was formed in January meaning investors will have to exercise extreme patience with this developmental company.
Medcaptain Medical Technology Pre-IPO Tearsheet
- Medcaptain Medical Technology (MMT) is looking to raise about US$100m in its upcoming Hong Kong IPO. The deal will be run by Morgan Stanley and Huatai International.
- Medcaptain Medical Technology is a global medical solution provider specializing in life support, minimally invasive intervention, and in vitro diagnostics.
- Its products are widely used across hospitals, clinics, testing facilities, and home care scenarios, addressing the needs of critical care, surgery, and diagnostics.
Pattern Group IPO: From Shaky Open to Strong Close as Buyers Step In
- The e-commerce accelerator priced 21.4 million shares at $14.00, the midpoint of the range, raising just under $300 million.
- Shares opened slightly below issue at $13.50, down 3.6% at the first trade but buyers quickly stepped in to stabilize the stock and finish 11.6% above issue.
- The stock’s ability to recover from a weak open and close well above issue indicates see value in this company.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
